6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
18m ago	Sky Harbour to Report Its First Quarter 2026 Financial Results and Host Webcast Investor Call on May 14th, 2026
18m ago	A&W FOOD SERVICES OF CANADA INC. ANNOUNCES RESULTS OF 2026 ANNUAL GENERAL MEETING
19m ago	Altus Group Announces Voting Results of 2026 Annual General and Special Meeting of Shareholders
1h ago	Aura Announces Q1 2026 Financial and Operational Results, Another High Record Adjusted EBITDA
1h ago	CrowdStrike Recognizes 2026 Americas Partners Driving Growth with the Falcon Platform

About

Aardvark Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aardvark Therapeutics Announces Leadership Appointments

Aardvark Therapeutics Announces Establishment of New U.S. Subsidiary to Support Development of Its Dermatology Pipeline; Bryan Jones Named Chief Executive Officer

How Aardvark Therapeutics, Inc. runs its investor program on 6ix — audience, formats, and program overview.

Recent Videos

Billionaires Pour Millions Into Aardvark Therapeutics

Billionaires Pour Millions Into Aardvark Therapeutics

May 02, 2026

How to Buy Aardvark Therapeutics Inc Stock (AARD)

How to Buy Aardvark Therapeutics Inc Stock (AARD)

Apr 08, 2026

Aardvark Therapeutics: ARD-101 Clinical Pause and Risk Synthesis AARD $AARD #AARD #stockmarket

Aardvark Therapeutics: ARD-101 Clinical Pause and Risk Synthesis AARD $AARD #AARD #stockmarket

Mar 02, 2026

OPWSA and FPWR Canada Webinar: Aardvark Therapeutics' HERO Phase 3 Clinical Trials for ARD-101

OPWSA and FPWR Canada Webinar: Aardvark Therapeutics' HERO Phase 3 Clinical Trials for ARD-101

Jan 19, 2026

Community Chat

Ask AI